Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

A new compound may treat benign prostatic hyperplasia better than finasteride.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Combining ciprofloxacin with other treatments may improve its effectiveness against resistant bacteria.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Probe detects finasteride with high selectivity and low detection limit.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.